Simplifying Peripheral Revascularization
FLEX VESSEL PREP™ SYSTEM
Designed for predictable and sustained outcomes
Reducing complications and improve long-term outcomes in PAD and AV Access
No capital equipment, only one or two SKU's to stock and optimizing DCB may reduce repeat interventions
Created by a vascular surgeon to address limitations of conventional vessel prep
FLEX VESSEL PREP™ SYSTEM
Designed for predictable and sustained outcomes
Reducing complications and improve long-term outcomes in PAD and AV Access
No capital equipment, only one or two SKU's to stock and optimizing DCB may reduce repeat interventions
Created by a vascular surgeon to address limitations of conventional vessel prep
Location: United States, Minnesota, Plymouth
Total raised: $43M
Funding Rounds 2
| Date | Series | Amount | Investors |
| 02.11.2025 | Series C | $28M | Endeavour ... |
| 15.08.2017 | Series B | $15M | - |
Mentions in press and media 11
| Date | Title | Description |
| 22.01.2026 | VentureMed Group Raises $28M in Series C Funding | VentureMed Group, a Minneapolis, MN-based medical device company, raised $28M in Series C funding. The round was led by S3 Ventures, with participation from existing investors including Endeavour Vision. The company intends to use the funds... |
| 22.01.2026 | Margarita Howard on How HX5’s Defense Origins Launched its Expansion into NASA Contracting | Through the third quarter of fiscal year 2024, NASA had directed $4.4 billion in prime contracting dollars to small business firms, a 20% increase over the previous year. x Please enable JavaScript Video Player is loading.Play Video Play Un... |
| 02.11.2025 | VentureMed: $28 Million Series C Raised For Advancing FLEX VP System And Global Vascular Care Expansion | VentureMed Group, a Minnesota-based medical device innovator focused on vessel preparation and access management technologies for peripheral arterial disease (PAD) and arteriovenous fistulas and grafts (AVF, AVG), announced the completion o... |
| 31.10.2025 | VentureMed Secures $28 Million to Propel Vascular Care Innovation | VentureMed Group, a medical device innovator, just closed a $28 million Series C funding round. This capital infusion accelerates the global reach of its FLEX Vessel Prep System. The system targets peripheral arterial disease (PAD) and arte... |
| 29.10.2025 | VentureMed: $28 Million Series C Raised For Expanding FLEX Vessel Prep System And Advancing Vascular Care | VentureMed Group, a Minnesota-based medical device company developing vessel preparation and access management technologies, has closed a $28 million Series C financing round led by S3 Ventures with participation from existing investor Ende... |
| 29.10.2025 | VentureMed Group Raises $28M in Series C Funding | VentureMed Group, Inc., a Minneapolis, MN-based medical device company, closed a $28m Series C financing round. The round was led by S3 Ventures, and joined by existing investors including Endeavour Vision. The company intends to use the fu... |
| 23.11.2021 | VentureMed Group Raises Convertible Note Along With Leadership Transition | MINNEAPOLIS, Nov. 23, 2021 /PRNewswire/ -- VentureMed Group, Inc., a privately held medical device innovator in access management for arteriovenous (AV) fistulas and grafts and vessel preparation for interventional treatment of peripheral a... |
| 21.10.2020 | FLEX Vessel Prep™ System Receives New Indication to Address In-Stent Restenosis | |
| 16.08.2017 | VentureMed Group Raises $15M Series B | TOLEDO, OH, Medical device company developing and commercializing next-generation endovascular products to treat patients suffering from peripheral artery disease (PAD), has raised $15M. >> Click here for more funding data on Ventu... |
| 15.08.2017 | VentureMed Group Raises $15M in Series B Funding | VentureMed Group, Inc., a Toledo, Ohio-based medical device company developing and commercializing innovative endovascular products to treat patients suffering from peripheral artery disease (PAD), raised $15m in Series B funding. The round... |
Show more